Dermatology
2 drugs are in development for Psoriasis.
- Companies
- 2
- Clinical trials
- 37
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Psoriasis pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(2)
| Drug | Company |
|---|---|
| dc-806 | DICE Therapeutics, Inc. (DICE) |
| edp2939 | Evelo Biosciences, Inc. (EVLO) |
About this indication
Psoriasis context
Dermatology·MeSH: Psoriasis (D011565)
Also known as: Psoriases
Prevalence
3000.0 / 100K
Incidence
78.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Psoriasis?
BioSniper tracks 2 drugs in development for Psoriasis across 2 companies.
How many clinical trials target Psoriasis?
There are 37 clinical trials targeting Psoriasis tracked by BioSniper.
What is the prevalence of Psoriasis?
The estimated prevalence of Psoriasis is approximately 3000.0 per 100,000 population.